| 1 |
34875337 | Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line. | 2022 Feb 15 |
1 |
| 2 |
33420743 | Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadism. | 2021 May |
1 |
| 3 |
32420164 | Do testosterone supplements enhance response to phosphodiesterase 5 inhibitors in men with erectile dysfunction and hypogonadism: a systematic review and meta-analysis. | 2020 Apr |
6 |
| 4 |
30987932 | Testosterone Deficiency and Endothelial Dysfunction: Nitric Oxide, Asymmetric Dimethylarginine, and Endothelial Progenitor Cells. | 2019 Oct |
1 |
| 5 |
29145710 | Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis. | 2018 Jan |
2 |
| 6 |
29256125 | Phosphodiesterase Inhibitors (PDE Inhibitors) and Male Reproduction. | 2017 |
1 |
| 7 |
25643866 | Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients? | 2015 Apr |
1 |
| 8 |
22971615 | Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency. | 2013 Jan |
3 |
| 9 |
23312193 | Re: combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-responders with severe and intermediate testosterone deficiency. | 2013 Feb |
1 |
| 10 |
23343170 | SOP conservative (medical and mechanical) treatment of erectile dysfunction. | 2013 Jan |
1 |
| 11 |
23892217 | [Role of androgen in the elderly. Male sexual dysfunction and androgen]. | 2013 Aug |
1 |
| 12 |
24350081 | Testosterone replacement therapy: should it be performed in erectile dysfunction? | 2013 Sep |
2 |
| 13 |
22028410 | Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling. | 2012 Jan 15 |
1 |
| 14 |
20704642 | Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). | 2011 Jan |
1 |
| 15 |
21834870 | Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). | 2011 Nov |
3 |
| 16 |
20057984 | [Testosterone and erectile dysfunction]. | 2010 Jan |
1 |
| 17 |
20584218 | Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. | 2010 Jun |
1 |
| 18 |
21045249 | [Testosterone deficit syndrome and erectile dysfunction]. | 2010 Oct |
3 |
| 19 |
19011292 | Erectile dysfunction and testosterone deficiency. | 2009 |
1 |
| 20 |
19138366 | Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study. | 2009 Feb |
1 |
| 21 |
19207276 | The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. | 2009 Mar |
1 |
| 22 |
19400854 | Sexual functions of men with obstructive sleep apnoea syndrome and hypogonadism may improve upon testosterone administration: a pilot study. | 2009 Jun |
1 |
| 23 |
19732305 | Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. | 2009 Dec |
1 |
| 24 |
21789066 | Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? | 2009 Oct |
2 |
| 25 |
18305486 | The relationship between hypogonadism and erectile dysfunction. | 2008 May-Jun |
2 |
| 26 |
16372114 | Recent insights into androgen action on the anatomical and physiological substrate of penile erection. | 2006 Jan |
1 |
| 27 |
16611151 | The management of phosphodiesterase-5 (PDE5) inhibitor failure. | 2006 Apr |
1 |
| 28 |
16651047 | Does testosterone have a role in erectile function? | 2006 May |
4 |
| 29 |
16939550 | The evolving role of testosterone in the treatment of erectile dysfunction. | 2006 Sep |
4 |
| 30 |
16979814 | Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. | 2006 Nov |
7 |
| 31 |
15822384 | [Ageing men's sexual functions decline and the erectile dysfunction (ED) increase]. | 2005 Feb |
1 |
| 32 |
16422803 | Testosterone therapy in erectile dysfunction and hypogonadism. | 2005 Nov |
1 |
| 33 |
16760638 | Phosphodiesterase type 5 inhibithors in older males. | 2005 |
1 |
| 34 |
14764637 | Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. | 2004 May |
1 |
| 35 |
11045039 | [The endocrine basis of sexual dysfunction in the elderly]. | 2000 Sep |
1 |